Document is current
Any future updates will be listed below
-
Authors
Wassmann, Sven
Weisser, Burkhard
Wilke, Thomas
Mevius, Antje
Randerath, Olaf https://orcid.org/0000-0003-1099-0856
Predel, Hans-Georg
- License Information
-
More Information
Article History
Received: 9 January 2026
Accepted: 21 May 2026
First Online: 8 June 2026
Declarations
:
: TW did studies for various pharmaceutical companies and received grants from Cytel Inc., a consultancy working for these companies. SW is on the speaker and advisory bureau of Amgen, Apontis, AstraZeneca, Berlin Chemie, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Lilly, Novartis, and Pfizer. OR is a member of the Medical Department of APONTIS PHARMA Deutschland GmbH & Co. KG, Germany. The remaining authors have no conflicts of interest to declare.
